Sort
261,768 grants matching “gene therapy”
Glucagon-Like Peptide-1 Receptor Agonist Treatment in Adult, Obesity-Related, Symptomatic Asthma
$1,583,667Katherine N Cahill · Vanderbilt University Medical Center · U01 · FY2024 · AI
Glucagon-Like Peptide-1 Receptor Agonist Treatment in Adult, Obesity-Related, Symptomatic Asthma
$1,583,667Katherine N Cahill · Vanderbilt University Medical Center · U01 · FY2022 · AI
Glucagon-Like Peptide-1 Receptor Agonist Treatment in Adult, Obesity-Related, Symptomatic Asthma
$1,583,667Katherine N Cahill · Vanderbilt University Medical Center · U01 · FY2025 · AI
A Program for Innovative PET Radioligand Development and Application - A Translational Toolbox for Treatments for Mental Health
$1,583,584Richard E Carson · Yale University · U01 · FY2022 · MH
Role of C-EBP transcription factors in cell growth and tumorigenesis
$1,583,541Peter F Johnson · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Novel Chemical and Immunological Approaches to Influenza Therapy
$1,583,376Michael B Oldstone · Scripps Research Institute, The · U01 · FY2008 · AI
Therapeutic Opportunities for Pediatric Astrocytoma
$1,583,141Rosalind A Segal · Dana-Farber Cancer Inst · P01 · FY2015 · CA
Genetic Analysis of Complex Inflammatory Disorders
$1,583,024Daniel Kastner · National Human Genome Research Institute · ZIA · FY2024 · HG
Lambda Genetic Networks and Lambda Red-Mediated Recombination
$1,582,938Donald Court · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA
Investigations of Methylmalonic Acidemia and Related Disorders
$1,582,664Charles P Venditti · National Human Genome Research Institute · ZIA · FY2015 · HG
Gene therapy targeting BCL11A to induce fetal hemoglobin and reduce sickle hemoglobin in patients with Sickle Cell Disease
$1,582,593David A Williams · Boston Children'S Hospital · R01 · FY2019 · HL
Gene therapy targeting BCL11A to induce fetal hemoglobin and reduce sickle hemoglobin in patients with Sickle Cell Disease
$1,582,593David A Williams · Boston Children'S Hospital · R01 · FY2018 · HL
Pig to Non-Human Primate Islet Xenografts
$1,582,592University Of Alabama At Birmingham · U19 · FY2005 · AI
Molecular Analysis Of Retroviral Genes And Their Products
$1,582,297Klaus Strebel · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI
Multi-functional anti-thrombotic therapy for coronary microvascular obstruction
$1,582,022Ridong Chen · Apt Therapeutics, Inc. · R44 · FY2023 · HL
Predicting Response to Standardized Pediatric Colitis Therapy: PROTECT Study
$1,581,943Jeffrey Samuel Hyams · Connecticut Children'S Medical Center · U01 · FY2015 · DK
1/1: ARREST RESPIRATORY FAILURE DUE TO PNEUMONIA (ARREST PNEUMONIA)
$1,581,887Joseph Eric Levitt · Stanford University · UH3 · FY2023 · HL
SPORE in Lung Cancer
$1,581,859Vanderbilt University · P50 · FY2001 · CA
Radiation-induced molecular targets
$1,581,677Norman Coleman · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Tumor Hypoxia: Molecular Studies & Clinical Exploitation
$1,581,538Amato J. Giaccia · Stanford University · P01 · FY2007 · CA
Mechanisms, Prevention and Treatment of Chronic Graft-vs.-Host Disease
$1,581,533Corey S Cutler · Dana-Farber Cancer Inst · P01 · FY2019 · CA
Function of ceramide in extracellular vesicle-mediated neurodegenerative disease
$1,581,504Erhard Bieberich · University Of Kentucky · RF1 · FY2022 · AG
Molecular Biology of Lymphoma
$1,581,430Mark Roschewski · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Bio-Therapies for the Treatment of Cancer
$1,581,108David Fitzgerald · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
GENE THERAPY FOR CYSTIC FIBROSIS
$1,580,779University Of North Carolina Chapel Hill · P01 · FY2000 · HL